Claudius Mueller
Overview
Explore the profile of Claudius Mueller including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
1089
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Berezovsky A, Nuga O, Datta I, Bergman K, Sabedot T, Gurdziel K, et al.
PLoS One
. 2025 Feb;
20(2):e0315171.
PMID: 39919036
Glioblastoma (GBM) tumors exhibit extensive genomic, epigenomic, and transcriptional diversity, with significant intratumoral heterogeneity, complicating standard treatment approaches involving radiation (RT) and the DNA-alkylating agent temozolomide (TMZ). In this study,...
2.
Mueller C, Davis J, Espina V
Expert Rev Proteomics
. 2024 Oct;
21(9-10):401-416.
PMID: 39474929
Introduction: Breast cancer subtyping is used clinically for diagnosis, prognosis, and treatment decisions. Subtypes are categorized by cell of origin, histomorphology, gene expression signatures, hormone receptor status, and/or protein levels....
3.
Berezovsky A, Nuga O, Datta I, Bergman K, Sabedot T, Gurdziel K, et al.
bioRxiv
. 2024 Oct;
PMID: 39386580
Glioblastoma (GBM) tumors represents diverse genomic epigenomic, and transcriptional landscapes, with significant intratumoral heterogeneity that challenges standard of care treatments involving radiation (RT) and the DNA-alkylating agent temozolomide (TMZ). In...
4.
Prasad D, Baldelli E, Blais E, Davis J, El Gazzah E, Mueller C, et al.
Br J Cancer
. 2024 Sep;
131(9):1543-1554.
PMID: 39322687
Background: Mutations of the PIK3CA/AKT/mTOR axis are common events in metastatic breast cancers (MBCs). This study was designed to evaluate the extent to which genetic alterations of the PIK3CA/AKT/mTOR can...
5.
Johnston L, Randall J, Chouraichi S, Luu M, Hunt A, Mauro L, et al.
NPJ Precis Oncol
. 2024 Sep;
8(1):203.
PMID: 39277699
Recent trials have shown the efficacy of trastuzumab deruxtecan (T-DXd) in HER2-negative patients, but there is not yet a way to identify which patients will best respond, especially with the...
6.
Lang J, Nguyen T, Levin M, Blas P, Williams H, Rodriguez E, et al.
Biomark Res
. 2023 Jul;
11(1):73.
PMID: 37491309
Background: A subset of triple-negative breast cancers (TNBCs) have homologous recombination deficiency with upregulation of compensatory DNA repair pathways. PIKTOR, a combination of TAK-228 (TORC1/2 inhibitor) and TAK-117 (PI3Kα inhibitor),...
7.
Wang J, Zhao Y, Tang L, Mueller C, Li Q
J Appl Stat
. 2022 Nov;
49(16):4278-4293.
PMID: 36353301
In disease screening, a biomarker combination developed by combining multiple markers tends to have a higher sensitivity than an individual marker. Parametric methods for marker combination rely on the inverse...
8.
Ghergurovich J, Lang J, Levin M, Briones N, Facista S, Mueller C, et al.
Med
. 2021 Jul;
2(6):736-754.
PMID: 34223403
Background: Upregulated glucose metabolism is a common feature of tumors. Glucose can be broken down by either glycolysis or the oxidative pentose phosphate pathway (oxPPP). The relative usage within tumors...
9.
Abbasi M, Fitzgerald S, Ayers-Ringler J, Espina V, Mueller C, Rucker S, et al.
Cureus
. 2021 Mar;
13(2):e13499.
PMID: 33777584
Thrombus characteristics are dependent on clot composition, but identification of the etiology based on histological analysis has proved inconclusive. Identification of proteomic signatures may help to differentiate between clots of...
10.
Haymond A, Damluji A, Narayanan A, Mueller C, Reeder A, Alem F, et al.
J Infect Dis
. 2021 Mar;
223(10):1677-1680.
PMID: 33718952
A cohort consisting of asymptomatic healthcare workers donated temporal serum samples after infection with severe acute respiratory syndrome coronavirus 2. Analysis shows that all asymptomatic healthcare workers had neutralizing antibodies,...